Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 16 | 2024 | 325 | 3.860 |
Why?
|
| Epigenesis, Genetic | 6 | 2024 | 219 | 1.690 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 643 | 1.320 |
Why?
|
| Monocytes | 3 | 2022 | 257 | 0.980 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 61 | 0.930 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 29 | 0.920 |
Why?
|
| MicroRNAs | 3 | 2024 | 426 | 0.860 |
Why?
|
| Obesity | 4 | 2024 | 1067 | 0.850 |
Why?
|
| Social Class | 1 | 2024 | 247 | 0.830 |
Why?
|
| Life Style | 1 | 2024 | 308 | 0.830 |
Why?
|
| Immunity | 1 | 2021 | 53 | 0.780 |
Why?
|
| Cytokines | 1 | 2024 | 602 | 0.730 |
Why?
|
| Genetic Markers | 1 | 2019 | 142 | 0.660 |
Why?
|
| Cytosine | 2 | 2016 | 33 | 0.640 |
Why?
|
| Hawaii | 6 | 2024 | 1929 | 0.630 |
Why?
|
| Humans | 32 | 2024 | 37093 | 0.610 |
Why?
|
| Insulin Resistance | 1 | 2019 | 184 | 0.590 |
Why?
|
| Central Nervous System | 1 | 2016 | 135 | 0.520 |
Why?
|
| Semiconductors | 1 | 2015 | 10 | 0.510 |
Why?
|
| Health Status Disparities | 1 | 2021 | 642 | 0.500 |
Why?
|
| Genome | 2 | 2015 | 125 | 0.500 |
Why?
|
| Diet | 1 | 2021 | 801 | 0.500 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 474 | 0.490 |
Why?
|
| HIV Infections | 2 | 2019 | 2303 | 0.470 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 7 | 0.460 |
Why?
|
| CpG Islands | 7 | 2024 | 97 | 0.450 |
Why?
|
| Exons | 1 | 2013 | 88 | 0.450 |
Why?
|
| Alternative Splicing | 1 | 2013 | 85 | 0.450 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 333 | 0.430 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 515 | 0.390 |
Why?
|
| Conserved Sequence | 2 | 2010 | 119 | 0.380 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2010 | 12 | 0.370 |
Why?
|
| Pilot Projects | 2 | 2024 | 661 | 0.370 |
Why?
|
| Genome, Human | 2 | 2013 | 135 | 0.370 |
Why?
|
| Histones | 4 | 2013 | 190 | 0.360 |
Why?
|
| Brain | 2 | 2024 | 1346 | 0.350 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 1015 | 0.330 |
Why?
|
| Inflammation | 2 | 2024 | 618 | 0.320 |
Why?
|
| Male | 11 | 2024 | 20025 | 0.290 |
Why?
|
| Middle Aged | 7 | 2024 | 10129 | 0.280 |
Why?
|
| Female | 10 | 2024 | 20969 | 0.270 |
Why?
|
| Cohort Studies | 3 | 2024 | 1492 | 0.250 |
Why?
|
| Organ Specificity | 3 | 2016 | 129 | 0.240 |
Why?
|
| HCT116 Cells | 2 | 2015 | 35 | 0.240 |
Why?
|
| Child, Preschool | 3 | 2024 | 1418 | 0.240 |
Why?
|
| Biomedical Research | 2 | 2021 | 400 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 3 | 2018 | 360 | 0.220 |
Why?
|
| Food | 1 | 2023 | 100 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2024 | 1378 | 0.210 |
Why?
|
| Food Supply | 1 | 2023 | 112 | 0.210 |
Why?
|
| Aged | 4 | 2024 | 6741 | 0.210 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 6 | 0.200 |
Why?
|
| Vaccines | 1 | 2022 | 55 | 0.200 |
Why?
|
| Dietary Fiber | 1 | 2021 | 47 | 0.200 |
Why?
|
| Cell Line | 4 | 2013 | 1354 | 0.200 |
Why?
|
| Disease Progression | 1 | 2024 | 601 | 0.190 |
Why?
|
| Simvastatin | 1 | 2021 | 29 | 0.190 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 40 | 0.190 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 234 | 0.190 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 885 | 0.190 |
Why?
|
| Lyases | 1 | 2021 | 51 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 123 | 0.180 |
Why?
|
| Mental Health | 1 | 2023 | 303 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 628 | 0.180 |
Why?
|
| Neuroglia | 1 | 2020 | 124 | 0.170 |
Why?
|
| Social Support | 1 | 2022 | 394 | 0.170 |
Why?
|
| Aging | 1 | 2024 | 664 | 0.170 |
Why?
|
| Animals | 11 | 2021 | 15081 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 282 | 0.170 |
Why?
|
| Selenoproteins | 1 | 2021 | 159 | 0.170 |
Why?
|
| Gene Silencing | 3 | 2010 | 151 | 0.160 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 120 | 0.160 |
Why?
|
| Parkinson Disease | 1 | 2020 | 178 | 0.160 |
Why?
|
| Diet, Gluten-Free | 1 | 2018 | 2 | 0.160 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 137 | 0.160 |
Why?
|
| Liver | 1 | 2021 | 479 | 0.160 |
Why?
|
| Child | 2 | 2024 | 3131 | 0.160 |
Why?
|
| Triglycerides | 1 | 2018 | 138 | 0.150 |
Why?
|
| Adolescent | 3 | 2023 | 5363 | 0.150 |
Why?
|
| Mice | 9 | 2021 | 5913 | 0.150 |
Why?
|
| Oligodendroglioma | 2 | 2008 | 5 | 0.150 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 4 | 0.140 |
Why?
|
| Logistic Models | 1 | 2019 | 923 | 0.140 |
Why?
|
| HIV | 1 | 2016 | 98 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1130 | 0.140 |
Why?
|
| Chromatin | 3 | 2013 | 169 | 0.130 |
Why?
|
| Carrier Proteins | 2 | 2010 | 305 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 97 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 111 | 0.130 |
Why?
|
| DNA Replication | 2 | 2013 | 152 | 0.130 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 69 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 306 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2015 | 40 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 767 | 0.130 |
Why?
|
| Self Care | 1 | 2015 | 159 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2013 | 326 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2013 | 8 | 0.110 |
Why?
|
| Adult | 4 | 2022 | 11712 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2013 | 29 | 0.110 |
Why?
|
| Phenotype | 2 | 2018 | 689 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 317 | 0.100 |
Why?
|
| Smoking | 1 | 2018 | 940 | 0.100 |
Why?
|
| Mutation | 1 | 2016 | 1095 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2011 | 41 | 0.100 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 10 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2010 | 48 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2021 | 933 | 0.090 |
Why?
|
| Japan | 2 | 2021 | 305 | 0.090 |
Why?
|
| Reference Values | 1 | 2010 | 212 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2010 | 76 | 0.090 |
Why?
|
| Environment | 1 | 2010 | 138 | 0.080 |
Why?
|
| Nicotine | 2 | 2024 | 257 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2008 | 55 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 578 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1371 | 0.070 |
Why?
|
| Cadherins | 1 | 2007 | 90 | 0.070 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 14 | 0.070 |
Why?
|
| Astrocytoma | 1 | 2005 | 14 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1609 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 63 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 108 | 0.060 |
Why?
|
| Receptors, Peptide | 1 | 2024 | 23 | 0.060 |
Why?
|
| Gene Expression | 2 | 2008 | 674 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 86 | 0.060 |
Why?
|
| Camptothecin | 1 | 2003 | 20 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2022 | 23 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 27 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 76 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 14 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2003 | 110 | 0.050 |
Why?
|
| Philippines | 1 | 2021 | 73 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2022 | 82 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 40 | 0.050 |
Why?
|
| Creatinine | 1 | 2021 | 103 | 0.050 |
Why?
|
| Neurons | 1 | 2008 | 1175 | 0.050 |
Why?
|
| Glutathione Peroxidase | 1 | 2021 | 111 | 0.050 |
Why?
|
| United States | 2 | 2022 | 4223 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 126 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 230 | 0.040 |
Why?
|
| Selenium | 1 | 2021 | 148 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 894 | 0.040 |
Why?
|
| Grooming | 1 | 2018 | 5 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 481 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1046 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2018 | 37 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 55 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 626 | 0.040 |
Why?
|
| Social Behavior | 1 | 2018 | 131 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 205 | 0.040 |
Why?
|
| Ectoderm | 1 | 2016 | 11 | 0.030 |
Why?
|
| Neural Tube | 1 | 2016 | 7 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 21 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2018 | 314 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1549 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 77 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 32 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 2026 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 54 | 0.030 |
Why?
|
| Point Mutation | 1 | 2016 | 93 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 610 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 153 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2007 | 807 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1398 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 938 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2008 | 435 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 502 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 164 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 239 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2379 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 286 | 0.030 |
Why?
|
| RNA | 1 | 2016 | 241 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2015 | 187 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1369 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 313 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 935 | 0.030 |
Why?
|
| Replication Origin | 1 | 2013 | 14 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 28 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2013 | 38 | 0.030 |
Why?
|
| S Phase | 1 | 2013 | 37 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2013 | 14 | 0.030 |
Why?
|
| Methylation | 1 | 2013 | 113 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2013 | 28 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 43 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 62 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2013 | 58 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 623 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 539 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 677 | 0.030 |
Why?
|
| Telomere | 1 | 2013 | 56 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 372 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2011 | 69 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4268 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 681 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 2231 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 223 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 421 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 78 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2007 | 90 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 523 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 195 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2005 | 7 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 513 | 0.020 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2005 | 9 | 0.020 |
Why?
|
| Retroviridae | 1 | 2005 | 22 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 448 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 71 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2005 | 49 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 587 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2005 | 158 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1568 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 18 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 617 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 177 | 0.010 |
Why?
|
| Computers | 1 | 2002 | 35 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 399 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2003 | 222 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 433 | 0.010 |
Why?
|
| Software | 1 | 2002 | 217 | 0.010 |
Why?
|
| Computational Biology | 1 | 2002 | 293 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1207 | 0.010 |
Why?
|